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Abstract. Endothelial cells that make up brain capil-
laries and constitute the blood-brain barrier become
different from peripheral endothelial cells in response
to inductive factors found in the nervous system. We
have established a cell culture model of the blood-
brain barrier by treating brain endothelial cells with
a combination of astrocyte-conditioned medium and
agents that elevate intracellular cAMP These cells form
T
HE blood-brain barrier (BBB),' interposed between
the circulatory system and the central nervous system
(CNS), is relatively impermeable to ions, many amino
acids, small peptides, and proteins. In vertebrates, the BBB
exists at the level ofthe endothelial cells (ECs) that make up
brain capillaries (Brightman, 1989). These ECs differ from
thoseinmost peripheralcapillaries in two important respects.
First, tight junctions with extremely high electrical resis-
tance are present between brain capillary ECs (Crone and
Olesen, 1982; Butt et al., 1990) . This limits the amount of
paracellular flux. Second, brain ECs undergo a relatively
slow rate offluid-phase endocytosis, as assayed by the uptake
of tracer molecules, such as HRP (Reese and Karnovsky,
1967). This limits the amount of transcellular flux. In short,
it is the combination ofthe limited paracellular and transcel-
lular movement that accounts for the existence of the BBB.
In recent years, the manner in which ECs in the brain be-
come different from those in the periphery has been exam-
ined. Stewart and Wiley (1981) found that ECs derived from
brain capillaries that are then permitted to vascularize pe-
ripheral tissue become relatively leaky. Conversely, ECs
originally derived from peripheral capillaries become less
leaky when they vascularize brain tissue. They concluded
that tissue environment influences EC phenotype. Janzer and
Raff (1987) showed further that type 1 astrocytes, which nor-
mally project to brain capillary ECs in vivo, are able to pro-
vide some of the inductive influences of brain tissue, again
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high resistance tight junctions and exhibit low rates of
paracellular leakage and fluid-phase endocytosis. They
also undergo a dramatic structural reorganization as
they form tight junctions. Results from these studies
suggest modes of manipulating the permeability of the
blood-brain barrier, potentially providing the basis for
increasing the penetration of drugs into the central
nervous system.
making ECs less leaky than they are when present in contact
with peripheral tissues.
These studies were both based on in vivo measurements
of cationic dye (e.g., Evan's blue) penetration, a procedure
that, in effect, assays albumin permeability since these dyes
generally bind tightly to albumin when introduced into the
circulation. Hence, they introduced some important ques-
tions. For instance, how does the CNS microenvironment
(or, more specifically, astrocytes) influence EC permeabil-
ity? Also, what factors found in the CNS cause ECs to be-
come brain-like?
In terms of the manner in which astrocytes affect EC per-
meability, there is no direct evidence that astrocytes cause
endothelial cells to form tight junctions of extremely high
electrical resistance. The available evidence indicates that it
seems likely that paracellular movement of albumin (and,
therefore, Evan's blue-albumin) across ECs will be limited
even when ECs are connected by tight junctions with
resistances much lower than 1,000 ohm-cm2 (Madara and
Dharmsathaphorn, 1985). Moreover, pial vessels, which are
not contacted by astrocytes in vivo (Bundgaard, 1982) are
able to form high resistance junctions (Crone and Olesen,
1982 ; Butt et al., 1990). Although several studies have
shown some influence of astrocytes on EC tight junction
structure assessed by microscopic techniques (Arthur et al.,
1987; Tao-Cheng et al., 1987; Tao-Cheng and Brightman,
1988; Shivers et al., 1988), there is again no certainty that
those ECs had formedjunctions ofhigh electricalresistance.
A reasonable conclusion is that whileastrocytes clearly have
an effect on EC permeability to large molecules in vivo, they
may not be the sole modulators of tightjunction resistance.
Clearly, it is crucial to determine the nature of the changes
induced in ECs by astrocytes and to identify other factors
that might influence EC permeability properties.
To understandhow such properties of brain ECs are regu-lated and also how they might be manipulated, a variety of
studies have focused on perfecting in vitro models of the
BBB. With few exceptions, these models have been based on
isolating and culturing brain ECs that appear to rapidly lose
at least some of their specialized properties. Occasional ex-
ceptions have been based on the use ofclonal populations of
cells(Rutten et al., 1987; Dehouck et al., 1990). That brain
ECs should become less "brain-like" when removed from
their normal environment is not total unexpected, given the
observations of Stewart and Wiley (1981) discussed above.
Our goal was to develop a cell culture system in which
monolayers of ECs with high resistance tightjunctions and
low rates of fluid-phase endocytosis couldbe grown reliably
on permeable filters. Our approach to this problem was
somewhat different than had been used in the past in that we
didn't rely solely on electrical resistance or molecular flux
measurements to characterize the cells. We reasoned that
ECs induced to form high resistance tightjunctions in cell
culture would be similar in morphology to MDCK cells, an
epithelial cell line that forms high resistance monolayers
(Gumbiner, 1987). In particular, MDCK cells show a char-
acteristic belt-like distribution ofseveral proteins that are as-
sociated with the junctioal complex including ZO-1
(Stevenson et al., 1986), filamentous actin (Gumbiner et
al., 1988), and E-cadherin (Behrens et al., 1985; Boller et
al., 1985; Gumbiner et al., 1988). E-cadherin, a Cal+-de-
pendent cell adhesion molecule, has been shown to function
in an essential way in tightjunction formation between epi-
thelial cells (Behrens et al., 1985; Gumbiner et al ., 1986,
1988). Vascular ECs also express cell adhesion molecules,
including cadherins (Heimark et al., 1990; Liaw et al.,
1990) and at least one member of the Ig superfamily
(PECAM; Newman et al., 1990) . Recently, we have also ob-
served E-cadherin-like immunoreactivity in brain capillaries
(F. Bard and L. L. Rubin, unpublished observations) . In this
paper, we describe a method that utilizes a combination of
astrocyte conditioned medium (CM) and elevated CAMP to
produce brain ECs that form high resistance tightjunctions
and adopt other properties characteristic of the BBB.
Materials andMethods
Bovine Brain ECs
Bovine brains were obtained fresh from a slaughterhouse and cleared of
meninges. Cortical grey matterwas collected incold L-15 medium, andcap-
illary fragments were prepared by homogenization and filtration through a
155-Am nylon mesh. Fragments were digested in 0.2% collagenase and
0.04% trypsin for 60 min at 37°C and plated on tissue culture flasks in a
medium consisting of50% astrocyte CM (see below) and 50% MEM con-
taining 10% plasma-derived horse serum (Hyclone Laboratories, Logan,
UT). Flasks had previously been coated overnight with rat tail collagen
(diluted to -100 wg/mlwith 1 mMacetic acid), rinsed with PBS, and coated
with human fibronectin (50 pg/ml in PBS; New York Blood Center, New
York). Control cells were maintained inthe same medium exceptthat astro-
cyte CM was replaced by MEM with 10% FCS. Both media were sup-
plemented with 10 ng/ml basic FGF (R & D Systems Inc., Minneapolis,
MN) and 123 pg/ml heparin (Sigma Chemical Co., St. Louis, MO) . When
ECs had reached confluence, they were trypsinized briefly to remove them
from the tissue culture flasks andplated at 20,000 cells/filter on 6.5 mm col-
lagen-fibronectin coated Costar Transwell filters (0 .4-Am pore size; Costar
Corp., Cambridge, MA) in a medium consisting of50% astrocyte CM and
50% N2 medium (Bottenstein and Sato, 1979). After an additional 2-3 d,
cells were either left untreated or incubated with 250 AM 8-(4-chlorophe-
nylthio) CAMP (CPTcAMP; Boehringer Mannheim, Indianapolis, IN) plus
17.5 AM ofthe phosphodiesterase inhibitor R020-1724 (BioMol, Plymouth
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Meeting, PA). Typically, cells were used 2-3 d later. At that point, cells
were treated for certain experiments with either sodium nitroprusside
(Sigma Chemical Co.), staurosporine (Kyowa Hakko USA Inc., Costa
Mesa, CA) or H-89 (generously provided by Drs. H. Hidaka, Department
of Pharmacology, Nagoya University School of Medicine, Nagoya, Japan
and V. John, Athena Neurosciences, Inc., South San Francisco, CA) .
For some experiments, cells were treated with different growth factors.
A preparation enriched in ciliary neurotrophic factor (CNTF) activity was
prepared from frozen rat sciatic nerves (Pel-Freez Biologicals, Rogers, AR)
according to theprocedures ofManthorpe etal. (1986). PDGF (R & D Sys-
tems) and insulin-like growth factor-1 (IGF-1; Amgen Biologicals, Thou-
sand Oaks, CA) were also used.
IsolationofBovine BrainECClones
Cloned cells were derived by isolating and passaging individual colonies of
primary ECs plated initially atlow density in tissueculturedishes (Dehouck
et al., 1990), but in the continual presence of astrocyte CM. These clones
could bepassagedmorethan 10 times (at a 1:10 split ratio), while maintain-
ing the ability to form monolayes with resistances exceeding 400 ohm-
cm2 when grown in the presence of astrocyte CM and CPTcAMP
HumanBrain ECs
Human brain ECs were obtained from freshly biopsied tissue provided by
Dr. N. Barbaro (Department of Neurosurgery University of California at
San FranciscoSchool of Medicine, SanFrancisco, CA). Approximately 1 g
ofstarting material was used, and isolationprocedures were similar tothose
described for bovine brain ECs.
Peripheral Bovine ECs
Bovine aortic ECs were isolated from aorta obtained freshfromthe slaugh-
terhouse as described by Liaw et al. (1990). Bovine adrenal microvascula-
ture endothelial cells were the kind gift of Dr. Martha Furie (Department
of Pathology, State University of New York, Stony Brook, NY).
Astrocyte-conditionedMedium
Astrocytes were prepared from 1-d-old rat cortex, essentially as described
by Lillien et al. (1988) . Briefly, -7 d after the initial dissociation, flasks
containing astrocytes were shaken overnight and the remaining cells (en-
riched in type 1 astrocytes) were trypsinized and replaced on poly-D-
lysine-coated flasks. The cells were treated with cytosine arabanoside
(10-s M) and maintained in serum-free medium as described by Lillien et
al. (1988) to limit the growth of more rapidly dividing cells, such as fibro-
blasts. By immunocytochemical criteria, thecultures were -95% type 1 as-
trocytes. For collection ofconditioned medium, cultures that were 3-4-wk-
oldwerefedwith fresh MEMcontaining 10% FCS. After 48 h, the medium
was removed, sterile-filtered, and either used immediately or stored at
-20°C.
Other Cells
Neonatal rat fibroblasts were derived from limb muscle, as previously de-
scribed (Anthony et al., 1989). U2-51 human astrocytoma cells were
provided by Dr. M. Shelanski (Department ofPathology, College ofPhysi-
cians and Surgeons, New York). C6-glioma cells were obtained from the
American Type Culture Collection (Rockville, MD). These cells were
maintained in MEM with 10% FCS, and CM was collected as described
for astrocytes.
Immunocytochemistry
For most experiments, immunofluorescence was done essentially as de-
scribed by Gumbiner et al. (1988). Cells were generally fixed for 20 min
in 3% paraformaldehyde and then permeabilized in 0.5% Triton X-100
(Sigma Chemical Co.) for 5 min. Alternatively, cells were permeabilized
in0.5 % Triton X-100before fixation(Heimark et al., 1990). Cells werethen
incubated for 60 min in primary antiserum diluted in 10% FCS in MEM.
After rinsing in PBS, cells were then incubated for 30 min in either FITC-
conjugated goat antirabbit, mouse (Accurate Chemical and Scientific
Corp., Westbury, NY) or rat Ig (Boehringer Mannheim), as appropriate,
diluted in MEM containing 10% FCS and 10% goat serum (Gibco BRL
Life Technologies Inc., Grand Island, NY). They were coincubated in
rhodamine-phalloidin (Molecular Probes Inc., Eugene, OR) to label
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filamentous actin . The cells were rinsed in PBS, mounted in CitiFluor
(Citifluor Ltd ., London, . U.K.), and examined on a Nikon microscope
equippedwith epifluorescent illuminationandeither20x, 40x, or60x ob-
jectives and photographed with Kodak TriX film (ASA 400) .
For some of these experiments (e .g ., Fig . 3), cells were incubated with
a rabbit antibody made against a bacterial fusion protein containing amino
acids 9-96 of canine E-cadherin fused to bacterial MS-2 polymerise
(Seedorf et al ., 1987; Liaw, C . W., K . J. Tomaselli, C . Cannon, D. Davis,
K . Bryant, and L . Rubin, manuscript submitted for publication ; see also
1990. J . Cell Biol. 111:408a.). Before use, antibody was affinity purified on
a Sepharose 4B column (Pharmacia LKB Biotechnology Inc., Piscataway,
NJ) containingboundgel-purified fusion proteinandshown to labelMDCK
epithelial cells and brain capillaries in cryostat section. Some nonspecific
nuclear fluorescence was observed with the affinity-purified antibody and
isprobably relatedto thepresence inthefusionprotein ofsequencesderived
from the bacterial polymerase .
Primary antibodies used for these experiments include a rat monoclonal
anti-ZO-1 (provided by Dr. Bruce Stevenson, Department of Anatomy and
Cell Biology, University ofAlberta, Edmonton, Canada), a mouse mono-
clonal antivascular cadherin antibody (provided by Dr. R . Heimark, Icos
Corp., Seattle, WA), and a rabbit polyclonal anti-PECAM antibody
(provided by DL S . Albelda, Wistar Institute, Philadelphia, PA) .
ResistanceMeasurements
Transwells were placed in a chamber containing MEM buffered with 20
mM Hepes . Resistance was measured using an assembly containing
current-passing and voltage-measuring electrodes (World Precision Instru-
ments Inc ., New Haven, CT) . Resistances of blank filters were subtracted
from those offilters with cells before final resistances (in ohm-cm2) were
calculated .
Measurement ofcAMP Levels
cAMP levels were measured by RIA (Dupont-NEN Products, Wilmington,
DE) following modification of the protocol of Stelzner et al. (1989) . Cul-
tures wererinsed two times with cold PBS and solubilized with 1 MNaOH .
Aliquots were taken for proteindeterminationand, afterneutralization with
1 M NaOH, forRIA . Occasionally, the cells were rinsed with PBS contain-
ing the phosphodiestemse inhibitor isobutyl-methylxanthine (Sigma Chem-
ical Co.) before extraction, but this was found not to influence measured
CAMP levels .
FluxMeasurements
Approximately 300 nM 1°C-sucrose (New England Nuclear) or 300
nM 3H-propranolol (New England Nuclear) were added to the apical
chamber, and the appearance ofthese compounds in the basolateral cham-
ber was measured at various times thereafter by scintillation counting of
small aliquots of the basolateral media . For comparison, flux across cell-
free filters was also measured . Transport is expressed as microliters of
tracer diffusing from apical to basolateral sides and is calculated from the
initial concentration of tracer in the apical and the final concentration of
tracer in thebasolateral chamber. Care was taken to ensure that fluid levels
in the two chambers wereequal (200 pl in the apical and 600 pl inthe basal
chambers), and chambers were kept at 37° during the course of the ex-
periment .
Fluidphase Endotytosis
Brain and peripheral ECs growing on Transwells were incubated for 2 h
Figure 1. Distribution oftightjunction-associatedproteins in brain
ECs. Bovine brain ECs grown on Transwell filters were labeled
with antibodies against ZO-1 (a), vascular cadherin (b) orPECAM
(c) . ZO-1 staining resembled that seen in other cells that form tight
junctions, either of high and low resistance types . Vascular.cadhe-
rin staining was more diffuse, andPECAM staining was junctional,
but somewhat broad in regions. The pattern of staining for these
cell adhesion molecules was different from that seen with the anti-
E-cadherin antibody (Fig . 3) . Also, the staining was not altered
substantially by the presence of astrocyte CM or elevated cAMP
Bar, 10 pm .Figure 2 . Effect of elevated cyclic AMP on distribution of filamentous actin . Bovine brain ECs grown in the presence of astrocyteCM
(a) or astrocyte CM plus CPT-CAMP plus R020-1724 (b) were fixed, permeabilized, and stained with rhodamine-phalloidin. Filamentous
actin was diffusely distributed in cells maintained either in control medium or in astrocyteCM . However, elevation ofcAMP in astrocyte
CM-treated cells produced a reorganization so that the filamentous actin staining was localized preferentially at cell borders. Bar, 20gm .
with 10 mg/ml fluorescenn-labeled dextran (Sigma Chemical Co .; approxi-
mate molecular weight 70,000; dialyzed extensively againstMEM before
use) in growth medium, rinsed and fixed in 396 paraformaldehyde. They
were then examined under fluorescent illumination. For comparison pur-
poses, photomicrographs ofthe different types ofcells were exposed forthe
same length of time .
For quantitative studies, fluorescenn-dextran (10 mg/ml) was added to
growth medium in the apical compartment . After 1-2 h at 37°, the apical
medium was aspirated, and the filters were washed threetimes quickly, and
once for 10 min with cold PBS containing 1 mM MgC12, 0.1 mM C;C12,
and0.3% BSA . Cells were then trypsinized at 4°, microfuged, rinsed, and
extractedin PBS containing 196 Triton X-100 and0.596 SDS. Fluorescence
was quantified on a microspectrofluorometer. Results were corrected for
fluorescence associated with the cells at 4° ; this was typically 10% ofthat
at 37°.
Results
Immunocytochemical Characterization ofBrainECs
Thedistributions in cultured brainECsofZO-1, filamentous
actin, and different cell adhesion molecules were deter-
mined. ECs obtained from bovine brain and maintained on
filters in cell culture, essentially following previously pub-
lished procedures (Audus and Borchardt, 1986), retained
their EC phenotype, asjudged by factor VIII antibody stain-
ing, for example. They also stained with an anti-Z04 anti-
body around theirborders (Fig . 1 a), as did peripheral ECs
derived from bovine aorta and human umbilical vein, both
of which form monolayers of low electrical resistance (data
not shown) . Vascular cadherin and PECAM immunoreac-
tivity were present as well, again just as on peripheral ECs
(Fig . 1, b and c) . However, filamentous actin, visualized by
staining with rhodamine-phalloidin, was distributed in the
cells in a diffuse stress fiber-like pattern, as opposed to the
belt-like distribution found in MDCK cells (Fig . 2 a) . Fur-
thermore, the E-cadherin-like immunoreactivity was weak
or absent around cell borders (Fig. 3a) . Importantly, the re-
sistance across monolayers of these cells was quite low, in
Figure 3. Effect of elevated cAMP on the distribution of E-cadherin immunoreactivity. Cells were grown as in Fig . 2 in either astrocyte
CM alone (a) or astrocyteCM plus elevatedcAMP (b) . They were fixed, permeabilized, and stained with an anti-E-cadherin fusion protein
antibody (see MaterialsandMethods) . IncreasedCAMP produced amarked increase in theamount ofstaining at cellborders. This increase
was noticeable 1 h after addition of CPT-CAMP Nuclear fluorescence was nonspecific (see Materials and Methods) . Bar, 10 Am .
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on Brain EC Resistance
Bovine brain and human brain ECs were prepared as described in Materials
and Methods. For cAMP experiments, cells were treated for 48-72 h with a
combination of CPT-cAMP plus R020-1724. Rresults in this table are average
resistances f standard deviations. Resistances were measured for three to six
filters for each condition and are calculated from four individual experiments
for bovine brain ECs and two for human brain ECs.
the range of 10-50 ohm-cm2 (Table I), and the leakage of
small and large molecules across these monolayers was com-
paratively high (see Fig. 7, bottom) . Thus, these cells failed
to constitute a legitimate model of the BBB.
Effects ofAstrocyte-conditioned Medium on
Brain ECs
It seemed quite possible that astrocytes would be capable of
influencing the differentiation ofbrain ECs in culture, as they
do in vivo. Astrocytes do not normally make direct contact
with ECs in vivo, but, rather, are separated from them by an
extracellular matrix. Therefore, the influence of astrocytes
may be mediated by a secreted factor.
To test for the presence ofsuch a factor, we compared ECs
cultured in the presence or absence of conditioned medium
(CM) from type 1 astrocytes prepared from neonatal rat
brain as described by Janzer and Raff (1987) for use in their
in vivo transplant studies. We found that treating ECs with
astrocyte CM produced somewhat sharper ZO-1 staining
(not shown) and approximately a twofold increase in trans-
monolayer electrical resistance (Table I). However, even in
CM-treated cultures, we did not obtain cell monolayers that
had electrical resistances higher than -200 ohm-cm' (with
the average being substantially less). Nor did we find that
this treatment produced the belt-like pattern of filamentous
actin staining and cadherin-like immunoreactivity that we
expected (Figs. 2 and 3).
Effect ofIncreased cAMPLevels on the Distribution of
Junctional Components
Since astrocyte CM by itselfwas not sufficient to fully induce
brain EC differentiation, we examined other factors that
might induce these cells. Numerous descriptions of nerve
endings on cerebral vasculature have been provided (Harik
et al., 1981; Goldstein and Betz, 1986), and neurotransmit-
ter-target cell interactions might involve changes in second
messengers. It has also been observed that second mes-
sengers cause some changes in epithelial and peripheral EC
permeability (Duffey et al., 1981; Smirnov et al., 1989;
Stelzner et al., 1989; Balda et al., 1990; Yamada et al,
1990), so we investigated the effects of second messenger
manipulation on brain EC morphology and resistance.
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We found that increasing CAMP levels in ECs already
treated with astrocyte CM caused a striking change in cell
morphology that was particularly impressive when the cells
were stained with rhodamine-phalloidin. Instead ofthe cyto-
plasmic pattern of staining described above, filamentous ac-
tin in cells treated with cAMPRelevating agents was highly
enriched at cell borders (Fig. 2 b). In addition, treated cells
showed enhanced staining with the anti-E-cadherin fusion
protein antibody around their borders (Fig. 3 b). This en-
hanced staining was seen by 1 h after cAMP elevation. The
distribution of ZO-1 also became more regular, but the
effects were subtle (data not shown). PECAM and vascular
cadherin staining did not change appreciably.
Effect ofElevated cAMP on Resistance ofBrain ECs
We found that agents that increased cAMP levels produced
a rapid increase in electricalresistance, again in cellsalready
treated with astrocyte CM (Table I; Fig. 4) . With time, the
resistance increased, on average, to over 600 ohm-cm2,
with maximum resistances of -1,500 ohm-cm, having been
achieved.
For most experiments involving increases in cAMP, cells
were treated with a combination of a cAMP analogue (CPT
cAMP) and a phosphodiesterase inhibitor (RO20-1724). How-
ever, other agents that elevate cAMP levels, including agonists
whose receptors are coupled to Gs (such as isoproterenol
and calcitonin gene-related peptide) cholera toxin, and for-
skolin were also effective. The most effective phosphodies-
terase inhibitors in our studies-were those that act on the
class of cAMP-specific, cGMP noninhibitable phosphodies-
terases (Beavo, 1988).
We also used an RIA to measure changes in cAMP levels
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Figure4. Effect ofchanges in cAMP on brainEC resistance. Bovine
brainECs were grown for 2 d on Transwells in medium containing
astrocyte CM. At the beginning ofthe experiment, resistances were
measured across cell monolayers. Resistance across individual
filters was then measured at the specified times and expressed as
percent ofthe initial value. In this, and all other figures, each point
represents the average resistance of two to four individual mono-
layers. In this experiment, cells were either maintained in astrocyte
CM alone (e) or treated with 17 .5,uMR0204724 in astrocyte CM
(o). The early transient fall in resistance is related to handling
during resistance measurements. Resistance increases rapidly when
cAMP levels increase, either in response to the R020-1724or after
addition of CPTcAMP or any of a variety of other agents that ele-
vate cAMP.
Condition Resistance
ohm-cm2
Bovine brain
Control 61 t 2
Astrocyte CM 115 t 11
cAMP 305 t 50
Astrocyte CM +CAMP 625 t 82
Human brain
Astrocyte CM 67 f 12
Astrocyte CM+cAMP 339 t 107C
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Figure 5 . Effect of astrocyte CM on the response to cAMP elevation . (a) Primary cultures of bovine brain ECs were grown in either
50% astrocyteCM (e) or 50% MEM with 10% FCS (o) from time of initial plating. Resistances across sets of filters were measured
(average starting resistance was -100 ohm-cm2 for CM-treated cells and 25 ohm-cm2 for untreated cells), and the cells were then treated
to elevate their CAMP levels . In this particular example, primary cells grown in astrocyteCM responded rapidly to increased cAMP,
whereas those not pretreated withCM did notrespond over a24-h period . Note that in the experiments presented in Table I, measurements
were made 48-72hafter elevation ofCAMP Results were similar if cells were treated with either CPT-cAMP or CPT-CAMP plus R020-
1724 . (b) Cloned bovine brainECswere maintained for 10 passages in astrocyteCM andpassaged into tissue culture flasks in the presence
(e) or absence (o,o) ofCM . After 7 d, the cells were passaged onto Transwells, and some ofthe cells were re-fed withCM (n) . After
two additional days, all cells were treated with CPTCAMP plus R020-1724 . Before treatment, cells grown in thepresence of astrocyte
CM had resistances of -35 ohm-cm2 ; those grown without CM were -25 ohm-cm2. As seen in this example, cloned brain ECs
responded less well tocAMP increases ifkept withoutCM . However, switching them back to CM restored their response. All resistances
are given as percentages of initial values.
in response to the various treatments . Thelevel ofcAMP in
untreated cultures varied from 60 to 100pmol/mg total pro-
tein, similar to that reported by Stelzner et al . (1989) forpe-
ripheral ECs. Both R0204724 and forskolin treatment pro-
duced atwoto threefold increase in cAMP levels within 1 h
of addition .
Importance ofAstrocyteCM in cAMP Effects
Although astrocyteCM itself did not have a large effect on
resistance or on cell morphology, itwas an important deter-
minant of the response to elevation of cAMP For instance,
in -25% of the experiments, the resistance of cells grown
without astrocyte CM did not increase significantly within
24-48 h ofCAMP elevation (Fig . 5 a; such experiments are
included when averages are presented) . In fact, even when
cells that were maintained in the absence of astrocyte CM
did show increased resistance, they generally took much
longer to respond than did the astrocyte CM-treated cells
(16 h, rather than 2 hor less). This wasalso reflectedin cell
morphology since the type of rhodamine phalloidin staining
illustrated in Fig. 2 b was seen only when cells were sub-
jected to the combination of CM and elevated cAMP
Other types of cell-derived CM were not as effective as
that from type 1 astrocytes (Table lI). Cells grown in rat
fibroblast CM, forexample, remained in amuch lower resis-
tance stateevenwhen treatedwith agents that elevate cAMP
Also, compared to cells maintained in astrocyte CM, cells
switched from astrocyteCM to othertypes ofCM, including
those derived from either U2-51 astrocytoma or C6-glioma
cells, showed asmaller increase in resistance upon elevation
of cAMP (Table II) .
Influence ofAstrocyteCMon Cloned Bovine
BrainECs
Primary EC cultures were not entirely free ofcontaminating
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cell types, and it was possible, that either astrocyteCM or
CAMP elevation affected other cells, such as pericytes, that
in turn influenced theECs . To address this issue, we isolated
several individual clones ofbovine brain ECs from colonies
of cells maintained from their time of isolation in astrocyte
CM . These cells also werecapableofbeing inducedto form
high resistance tight junctions when CAMP levels were
elevated. When cloned cells were removed from astrocyte
CM for several days, they did notresponse to elevatedCAMP
as well (Fig . 5 b) . When astrocyteCM was added back to
those cells for24-48 h, they again showed an enhanced abil-
ity to respond to CAMP elevation (Fig . 5 b) .
Table II. Effects of Various ConditionedMedia on
Brain EC Resistance
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BovinebrainECswere isolated and maintained in flasks in either astrocyteCM
(ACM) or neonatal rat fibroblastCM (FCM) . This is referred to as the initial
CM . They were thenpassaged onto Transwells and maintained in ACM, FCM,
U2-51 astrocytomaCM,or C6 gliomaCM (C6CM). This is referred to as the
final CM . Each type ofCM was collected from confluent cultures maintained
in MEM with 1096 FCS and was diluted 1 :1 with freshmedium before use .
Aftertwo days, resistances were measured (pre-CAMP), and the cells were
treated with CPT-CAMP plus R020-1724 . Resistances were measured again
after an additional two days (post-cAMP) . Resistances are given as percen-
tages, with the resistances of pre-CAMP cells maintained in ACM defined as
10096 ; resistances ofthese cells ranged from 35 to 45 ohm-cm' .
Treatment Relative resistance
Initial CM Final CM pre-CAMP post-CAMP
Expt . 1 ACM ACM 100 945
FCM FCM 98 219
Expt.2 ACM ACM 100 921
ACM FCM 78 113
ACM U2-51 CM 89 593
Expt.3 ACM ACM 100 1,181
ACM C6 CM 85 427time (hours)
Figure 6. Effect ofelevated cGMPon resistanceofbrainECs. Cells
were treated for 48 h with CPT-CAMP plus R0204724, but then
received various concentrations ofsodium nitroprusside to increase
cGMP levels (o, control; o, 0.1 AM; n, 1 KM; o, 10,M ; w, 100
KM). Resistances decreased rapidly when cGMP levels were in-
creased even in cells that had elevated cAMP Again, resistances
are expressed as percent of initial values.
Preliminary Characterization ofAsttocyte CMFactor
To begin to study the active factor(s) in astrocyte CM, we
carried out a preliminary characterization. Astrocyte CM
was collected in either defined medium or in MEM without
additional additives over a 24-48-h period. Both types of
CM were effective compared to the appropriate control me-
dia. The active factor was also heat-sensitive. The activity
of astrocyte CM could not be accounted for fully by PDGF
(Pettmann etal ., 1985 ; Richardson etal., 1988), CNTF (Lil-
lien et al., 1988), IGF-1, or FGF (data not shown).
ResponseofHumanBrainECs toAstrocyte CMand
ElevatedCAMP
To test the generality of these observations, we isolated ECs
from a limited number of human brain biopsies and treated
them with a combination ofastrocyte CM and agents that ele-
vate CAMP (Table I). Again, we were able to obtain cells
with relatively high electrical resistance and a similar belt-
like distribution of filamentous actin. Interestingly, on aver-
age, the resistance was somewhat lower than we were able
to obtain with bovine brain ECs, and, correspondingly, the
filamentous actin staining was not restricted exclusively to
cell borders.
EffectsofElevatedcGMPonBrain ECResistance
CAMP was not the only secondmessenger capable of altering
resistance ofbrain ECs. Cells whose resistance had been in-
creased by treatment with CPTCAMP were treated in addi-
tion with sodiumnitroprusside to elevatecGMPlevels (Wald-
man and Murad, 1987) . Fig. 6 shows the dose-dependent
decrease in resistance produced by this treatment. Thus, in-
creased cGMP appears to oppose the effects of increased
cAMP Atrial natriuretic factor, another agent that elevates
cGMP levels in ECs (Waldman and Murad, 1987), had simi-
lar effects (data not shown) .
TkansportofCompoundsacross HighResistance
Monolayers ofBrainECs
The high electrical resistance of induced bovine brain EC
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cultures suggests that they should be rather impermeable to
hydrophilic compounds. This was tcsted with fluorescent
dextrans of different molecular weights and with radioac-
tively labeled compounds that are not transported by specific
membrane transporters. We found that the high resistance
cells offered a significant permeability barrier to even small
hydrophilic compounds such as sucrose (Fig. 7, top) whereas
lower resistance monolayers were more permeable (Fig. 7,
bottom). However, as expected, there was marked flux of hy-
drophobic compounds across even high resistance monolay-
ers (Fig. 7, top). Hydrophobic compounds are capable of
crossing the BBB in vivo as well.
Fluid-PhaseEndocytosisin Brain andPeripheral ECs
Another hallmark of ECs in the brain is their low rate of
fluid-phase endocytosis (Reese and Karnovsky, 1967). This
is a nonsaturable, temperature-dependent process that is as-
sayed by incubating cells with labeled compounds for which
there are no specific transport mechanisms (Steinman et al.,
uL
Figure 7 . (Top) Flux of compounds across high and low resistance
monolayers of brain ECs. Flux was measured using radioactively
labeled compounds added to one side of filters with or without
cells. Leakage of small, hydrophilic compounds, such as sucrose
across high resistance monolayers (o) was limited compared to
that occurring across filters without cells (o). However, hydropho-
bic compounds, such as propranolol, moved rapidly across high re-
sistance monolayers (e) and across cell-free filters (m). (Bottom)
Sucrose flux across low resistance monolayers (m) is less than that
occurring across cell-free filters (o), but much greater than that
across high resistance monolayers (o) .
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Figure 8 . Fluid-phase endocy-
tosis inbovinebrainand aortic
ECs. Aortic cells showed rela-
tively pronounced uptake of
fluorescein-labeled dextran at
37°C (a), but not at 0°C (b) .
Brain ECs, on the other hand,
pinocytosedsignificantlysmall-
eramountsofthetracerat37°C
(c). Quantitative studies, using
either fluorescein-dextran or
HRP, indicated that the rate
of uptake of aortic or bovine
microvasculature ECswas ap-
proximately 1.0 nl/filter/h at
37°C while that of brain ECs
(eitherprimary orcloned cells)
was0 .25 nl/filter/h. Bar, 10Am .
1983) . Formeasurements ofendocytosis, brain ECs (treated
with astrocyte CM and CPTcAMP) and bovine aortic and
peripheral microvasculature ECs were incubated with fluo-
rescentdextran . Uptake into theperipheral ECs wasreadily
observed at 37° (Fig . 8 a), but barely detectable at 0° (Fig.
8 b) . Uptake into brain ECs was low at 37° (Fig . 8 c) .
Therate of fluid-phase endocytosis by brainECs remained
low under all growth conditions. Removal of astrocyteCM
did not affect the rate of pinocytosis, nor did elevation of
cAMP Similarly, the ratewasnotaltered specifically in aor-
tic ECs by either elevationofCAMP or by theaddition of as-
trocyteCM (data not shown) .
Effect ofDecreasingcAMP Levels on EC Resistance
Regardless of the agent used to elevate levels of CAMP in
brain ECs, upon its removal, transmonolayer resistances
dropped relatively rapidly (within 15-30 min; Fig. 9) . The
filamentous actin distribution also changed, butmore slowly
(see Fig. 11) .
The most straightforward explanation for the ability of
cAMP to increase resistance is that protein kinase A medi-
ates thephosphorylation of oneor more proteins important
in regulating the resistance of tight junctions. Therelatively
rapid decrease in resistance following removal of cAMP-
elevating agents suggests the presence of an active phos-
phoprotein phosphatase. This further suggests that while
cAMP levels remain elevated, kinase A must act to keep
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Figure9 . ReversibilityofcAMP effects onbrainECresistance. Cells
were maintained inastrocyteCM andwere treatedwith CPT-CAMP
plus R0204724 for 48 h before the start ofexperiment . At the start
oftheexperiment, resistancesweremeasured, and filterswererinsed
and replaced in either the same medium (o) or in astrocyteCM
alone (e) .The resistance is seentodecrease rapidly after removalof
cAMP elevating reagents.
regulatory proteins in a phosphorylated state in spite of the
presence of active phosphatases . Thus, inhibitors of protein
kinase A should act to decrease resistance even in the pres-
ence of elevated cAMP
We tested the effects of a variety of protein kinase inhibi-
tors on resistance of brain ECs continuously treated with
CPTcAMP We did find that two potent, butsomewhat non-
specific, proteinkinase inhibitors, staurosporineandK-252a
(Koizumi et al ., 1988 ; Hashimoto and Hagino, 1989), were
quite effective in decreasing resistance across EC mono-
layers (Fig. 10) . We also found that H-89 (Chijiwa et al .,
1990), anewlydescribedkinase inhibitor, that is less potent,
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Figure 10 . Effects of protein kinase inhibitors on resistance of brain
ECs . Cellswere grown for48 h in astrocyte CM containing CPT
cAMP plus R020-1724 . Resistances were measured and cells were
incubatedwith either 100nM staurosporine (e) or 25 I.M H-89 (o)
in the continued presence of CPTcAMP plus R020-1724 . Resis-
tances were measured at various intervals and expressed as percent-
ages of their initial values . Kinase inhibitors were dissolved in
DMSO, which, atthe concentrations used (<O.25 ° rb), hadno effects
on resistance . Both kinase inhibitors caused the resistance to de-
crease even inthe continued presence ofelevated CAMP, but stauro-
sporine was more effective .butmore selective for protein kinase A, also decreased resis-
tance in the presence of elevated cyclic AMP (Fig . 10) .
Staurosporine also produced morphological changes in
the cells, visualized by staining with rhodamine-phalloidin,
that took place several hours after the decrease in resistance
(Fig . 11) . These changes, which were similar to those seen
after removing CPTCAMP, did not represent a simple rever-
sion to a state of diffuse staining . Rather, the cortical-type
staining still was predominant, but became broader in the
regions of cell-cell contact, and there were visible gaps of
actin stain between adjacent cells .
Discussion
Establishment ofa Cell CultureBBBModel System
Understanding how the permeability ofthe BBB is regulated
is important for several reasons . First, initial therapeutic
treatments for a variety of neurodegenerative disorders will
likely be based upon the use of compounds, neurotrophic
factors, for example, that do not enter freely into the CNS,
and it will be important to have methods for enhancing their
CNS penetration . Second, there are a set ofneurological dis-
orders, such as vasogenic brain edema and multiple sclero-
sis, that involve a compromisedBBB. In fact, because ofthe
possible presence of peripheral circulating amyloid, it has
even been speculated that Alzheimer's disease involves an al-
teration inBBB permeability (Joachim et al ., 1989) . Finally,
there are instances of undesired cell trafficking into the
brain, such as that occurring with HIVinfected monocytes
or metastatic cells . These considerations make an under-
standing of the factors that control BBB permeability and
means for manipulating them in vivo of great importance .
In this paper, we describe methods for producing mono-
layer cultures of brain ECs whose properties are similar to
those expressed by these cells in vivo . These properties in-
clude high resistance tight junctions, low rates of fluid-phase
endocytosis, and restricted paracellular flux . The major
modification thatwe made of previous procedures was to in-
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Figure 11. Effectof staurosporine ondis-
tribution offilamentous actin . Brain ECs
weregrownas in thelegendtoFig . 10and
treated with 100nM staurosporine. Cul-
tures were fixedafter4 h andlabeledwith
rhodamine-phalloidin. Concomitant with
the decrease in electrical resistance, stau-
rosporine caused a significant change in
the distributionoffilamentousactin, sim-
ilar to that seen when CPTCAMP was
removed from treated cultures. Arrows
point to gaps between bands of filamen-
tous actin in adjacent cells. Bar, 20 ,m .
clude astrocyte CM from the time of cell isolation and sub-
sequently treat the cells with agents that elevate EC CAMP
levels . Most of our results were obtained with ECs derived
from bovine brain . However, in a limited number of experi-
ments similar treatments seemed to be effective withECs de-
rived from adult human brain . These experiments thus
potentially provide an increased understanding of factors
that regulate the BBB .
Until recently, there had been some difficulty in establish-
ing EC monolayers with properties appropriate to the BBB,
particularly high resistance tightjunctions and minimal leak-
age of small hydrophilic molecules . Generally, in these
cases, primary cultures ofbrainECs were isolated and main-
tained using standard cell culture conditions without further
inductive factors (Audus and Borchardt, 1986 ; van Bree et
al ., 1988) . In addition, based on the observation that astro-
cytes are important in EC differentiation, attempts had been
made to influence the differentiation ofbrainECs with astro-
cytes or astrocyte-derived factors . Dehouck et al. (1990)
found that coculturing astrocytes with ECs increases their re-
sistance even more although no effect was seen with astro-
cyteCM . Others found that astrocytes or astrocyte-derived
factors produced an increase in the complexity or frequency
of tight junctions, as seen with freeze-fracture microscopy
(Arthur et al., 1987; Tao-Cheng et al., 1987; Shivers et al .,
1988 ; Tao-Cheng and Brightman, 1988) . We found that CM
derived from neonatal type 1 astrocytes alone caused only
a small increase in resistance and, at best, subtle changes in
cell morphology. As pointed out above, it has never been
demonstrated that astrocytes exert a major influence on tight
junction resistance in vivo, and we feel that this question re-
mains to be resolved .
To overcome some of the inconsistencies associated with
primary cultures, Rutten et al . (1987) and Dehouck et al .
(1990) isolated clones of brain ECs that formed high resis-
tance monolayers in the absence of added factors . We also
isolated clones ofbrain ECs ; however, they still required as-
trocyteCM and elevatedcAMP to form high resistance tight
junctions. At this time, we cannot account for the differences
1733between our results and those obtained by these other
groups .
In our studies, we used some assays that had been em-
ployed routinely by other investigators studying brain ECs,
namely, resistance measurements and molecular flux . How-
ever, we also carried out a fairly extensive immunocyto-
chemical analysis of these cells that allowed us to achieve a
monolayer characterized by the uniform localization around
cell borders of several proteins known to be associated with
epithelial cells that form high resistance tight junctions. Of
the proteins that we examined, the distributions of filamen-
tous actin and a protein immunologically related to E-cad-
herin were substantially different in treated than in untreated
cells . ZO-1 staining was present between peripheralECs and
did not change as dramatically following CAMP elevation .
Thus, consistent with other observations (Schnabel et al .,
1990), it appears to be a less sensitive indicator ofthe degree
oftightjunction formation . The distributions ofPECAM and
vascular cadherin also were not altered by our treatments,
and, hence, do not seem to be strongly associated with the
formation of tight junctions of high resistance. On the other
hand, the distribution of E-cadherin immunoreactivity al-
teredmoredrastically during the induction ofhigh resistance
tightjunctions, suggesting that it mightsomehow be involved
in the formation of these junctions . We have not yet com-
pletely characterized the E-cadherin-like protein .
Regulation of 71ght Junction Resistance in BrainECs
One ofthe major observations in this paper is that tight junc-
tion resistance in brain ECs is regulated by second mes-
sengers, including cAMP and cGMP Similar results were
achieved with bovine andhuman brainECs . Further, we and
others (Duffey et al., 1981 ; Balda et al ., 1990 ; Rubin, L .,
unpublished observations) have accumulated evidence that
tight junction resistance in epithelial cells is also subject to
second messenger modulation . A likely explanation, for at
least the CAMP effect, is that the state of phosphorylation of
one or more proteins associated with the tightjunction is im-
portant in determining the permeability ofthe tight junction .
In this way, the tightjunction can be viewed like an ion chan-
nel or like the gap junction channel, with its permeability
being modified by the physiological state of the cell . This
is consistent with suggestions made previously (Madara,
1988) .
The effects of elevated CAMP on brain ECs were particu-
larly pronounced onlywhen they were pretreated with astro-
cyte CM . This was seen both in primary cultures of brain
ECs and also in clonal brain EC cultures . This makes it
likely that the effects of astrocyte CM (and of elevated
cAMP) were directly on ECs . There are other instances in
which growth or serum factors have been shown to potenti-
ate the effects of second messengers (Barres et al ., 1989) .
The identity and the manner in which the astrocyte factor
primes ECs to respond toCAMP elevation are currently un-
der investigation . Our model system should facilitate greatly
the identification of this factor.
CM derived from other cell types was not nearly as effec-
tive as that obtained from astrocytes . In particular, that de-
rived from an astrocytoma cell line and a commonly used
glioma cell line were not as effective even if the cells were
grown initially in astrocyte CM . They weremuch less effec-
tive still if ECs were maintained from time of isolation in
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these other types ofCM . These results are potentially in-
teresting in thatCNS tumors areassociated with a leakyBBB
(Greig, 1989) . It may be that CNS tumors either secrete a
factor that increases the permeability of brain ECs (like the
vascular permeability factor produced by peripheral tumor
cells ; Connolly et al ., 1989) or that these cells simply fail
to produce the normal astrocyte factor.
Regulation ofBBB Permeability In irvo
The real question that arises from thecAMP experiments is
the degree to which they are relevant to understanding the
BBB in vivo . Recently, we have attempted to address this in
a preliminary fashion by giving rats intracarotid infusions of
staurosporine, which, as shown in this paper, increases tight
junction permeability substantially in vitro. This inhibitor
increased three to fivefold the ability of peripherally ad-
ministered sucrose and BSA (both radioactively labeled) to
enter the brain, supporting the possibility thatCAMPmay be
an important regulator in vivo . However, more work needs
to be done to validate this theory.
This hypothesis also suggests that there might be physio-
logical factors that regulate cAMP levels in brain ECs in
vivo. Such factors might include ones derived from astro-
cytes or a variety of neurotransmitters and peptides released
from nerve terminals on cerebral capillaries (Harik et al.,
1981 ; Goldstein and Betz, 1986) .
Conclusions
In summary, we have derived an in vitro model of the BBB
in which brain ECs are induced to maintain a differentiated
state with a combination ofastrocyte CM and treatment with
agents thatelevatecAMP Our results also suggest that agents
that elevate cAMP levels increase tight junction resistance
and those that decrease cAMP levels or block its physiologi-
cal activity decrease tight junction resistance . Thus, we
would suggest that a delivery system designedto enhance the
penetration of compounds into the brain might be based on
agents that selectively decreaseCAMP activity in brain ECs .
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